Sequencer Products: SEQ ALL
Technologies
Applications
Online Resources
Data Bulletins
Service & Support
Introduction
Newsroom
Doing Business With Us
Creative Club
Statement
In response to the interim ruling by the Hong Kong High Court on 25 February 2021 regarding Illumina’s patent lawsuit against MGI, MGI makes the following statement: MGI welcomes the court’s deci...
More2021-02-25
MGI
To Develop and Promote Advanced Life Science Tools for Future Healthcare
HotMGI's DNBSEQ-T7 Powers YUCEBIO to Accelerate the Development of Clinical Application of Tumor Immunodiagnosis and TreatmentMGI’s sequencing platform in the YUCEBIO’s lab SHENZHEN, China, Feb 24, 2021-- MGI’s ultra-high-throughput gene sequencer, DNBSEQ-T7, is installed in Yukang Medical Laboratory of YUCEBIO. YUCEB...More2021-02-24
StatementIn response to the rulings of the Patents Court within the High Court of Justice for England & Wales on 18 February 2021, MGI makes the following statement: We welcome the Court’s decision to gi...More2021-02-20
HotChina's MGI Tech helps Latvia combat COVID-19 by providing testing equipmentA staff member of BIOR, Latvia's Institute of Food Safety, Animal Health and Environment, operates smart automated DNA extraction equipment provided by China's MGI Tech Co., Ltd. in Riga, Latvia (Ph...More2021-02-15
HotMGI's "Super Sequencer" Helps Sweden's National Pandemic Center Monitor COVID-19 MutationsSTOCKHOLM, Feb. 10, 2021 -- MGI Tech Co., Ltd. ("MGI")'s high-throughput gene sequencer has helped the regions throughout Sweden greatly improve their COVID-19 testing capabilities from the laborat...More2021-02-10
HotHigh throughput and low cost! MGI Helps the Scientific Institute "BIOR” fight against the COVID-19The pandemic has recently been spreading rapidly across the world, posing a formidable challenge to global public health system. As an important measure for the COVID-19 prevention and control, how ...More2021-02-09
